Mechthild Jonas
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- Immunology and Allergy top 2%
Papers in
-
- Cell Adhesion Molecules Research 8
- Oncology 20
- HER2/EGFR in Cancer Research 11
- CAR-T cell therapy research 4
- Co-authors
- Y. EmilGustavo Matute‐BelloE YEmil ChiWilliam R. HendersonW. Conrad LilesThomas R. MartinKenneth P. Steinberg
- Journals
- Cancer Research (8 papers)Blood (6 papers)Molecular Cancer Therapeutics (4 papers)Infection and Immunity (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- United StatesTaiwanNetherlands
In The Last Decade
Mechthild Jonas
41 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 1.1k
- Immunology and Allergy 310
- Oncology 976
- Microbiology 198
- Physiology 763
Countries citing papers authored by Mechthild Jonas
This map shows the geographic impact of Mechthild Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mechthild Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mechthild Jonas more than expected).
Fields of papers citing papers by Mechthild Jonas
This network shows the impact of papers produced by Mechthild Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mechthild Jonas. The network helps show where Mechthild Jonas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mechthild Jonas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 28 | |
| 2 | 2023 | 12 | |
| 3 | 2017 | 53 | |
| 4 | 2016 | 231 | |
| 5 | 2016 | 2 | |
| 6 | Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index Hit paper breakdown → | 2015 | 390 |
| 7 | 2009 | 32 | |
| 8 | 2008 | 218 | |
| 9 | 2008 | 60 | |
| 10 | Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies | 2007 | 2 |
| 11 | 2004 | 39 | |
| 12 | 2002 | 339 | |
| 13 | 2001 | 218 | |
| 14 | 2001 | 28 | |
| 15 | 1999 | 291 | |
| 16 | 1998 | 22 | |
| 17 | 1998 | 35 | |
| 18 | 1997 | 316 | |
| 19 | 1997 | 137 | |
| 20 | 1996 | 282 |
About Mechthild Jonas
Mechthild Jonas is a scholar working on Immunology and Allergy, Oncology, Immunology, Microbiology and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 3.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Cell Adhesion Molecules Research (8 papers), CAR-T cell therapy research (4 papers), Immune Response and Inflammation (4 papers), Asthma and respiratory diseases (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Blood disorders and treatments (3 papers). The work is most often cited by research in Immunology (1.1k citations), Immunology and Allergy (310 citations), Oncology (976 citations), Microbiology (198 citations) and Physiology (763 citations). Mechthild Jonas has collaborated with scholars based in United States, Taiwan and Netherlands. Frequent co-authors include Y. Emil, Gustavo Matute‐Bello, E Y, Emil Chi, William R. Henderson, W. Conrad Liles, Thomas R. Martin, Kenneth P. Steinberg, Robert P. Lyon and Martha E. Anderson. Their work appears in journals such as Cancer Research, Blood, Molecular Cancer Therapeutics, Infection and Immunity and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.